ARCA biopharma (NASDAQ:ABIO) Now Covered by StockNews.com

StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance ABIO stock opened at $2.40 on Friday. The stock has a market capitalization of $34.82 million, a P/E ratio of -5.71 […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on Endeavor Group (NYSE:EDR)
Next post Creative Media & Community Trust Co. (NASDAQ:CMCT) Earns Sell Rating from Analysts at StockNews.com